A multidisciplinary panel of experts provides an overview of the economic burden of HIV and the role of pre-exposure prophylaxis (PrEP) in preventing HIV transmission. Ian Frank, MD and Jeffrey ...
HIV pre-exposure prophylaxis (PrEP) is a prevention strategy which includes the regular or event-driven use of antiretroviral medication to prevent HIV infection in adults. Several clinical trials ...
Local health officials report a decline in HIV prevalence, with new cases dropping below 200. The Women's Collective plays a ...
A brand new drug might be more effective at preventing HIV than current methods. Many people take daily oral antiretroviral medication—known as PrEP (pre-exposure prophylaxis)—to protect themselves ...
Kind Clinic of Austin Koenig is holding its same-day HIV prevention medication pilot program starting March 13 until April 17.
From its 17-year development cycle through to its commercial launch, production has always been in Yeztugo’s DNA. | From its ...
Pre-exposure prophylaxis (PrEP) is a medication regimen that is used to protect at-risk populations from HIV infection. The FDA approved the drug TRUVADA ...
MONTRÉAL, March 25, 2025 /CNW/ - ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. (PFE) and Shionogi as shareholders, is pleased to ...
HIV spreads in the human body by targeting and infecting T cells, the critical white blood cells of our immune system. PrEP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results